⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for Remission
prnewswire.com
JNJ
Modicus Prime Raises $8M to Enable AI Audit Readiness Across Pharma
prnewswire.com
JNJ
CURE Media Group and Oncology Nursing News® Announce the 2026 Extraordinary Healer® Award Finalists and Keynote Speaker Teddi Mellencamp
globenewswire.com
JNJ
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP
AI in GxP Environments | 9-Hour Online Training Course - Provides Frameworks for Decision-Grade AI Implementation Vital for QA, Regulatory, and Governance Professionals
globenewswire.com
JNJ
MRK
SNY
GSK
Breast Cancer Canada’s annual Walk-a-Thon to Mother’s Day returns to advance breast cancer research.
businesswire.com
AMGN
MRK
PFE
BMY
GILD
ABBV
AZN
JNJ
LULU
Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease
prnewswire.com
JNJ
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
prnewswire.com
JNJ
Longwood Healthcare Leaders to Host MIT CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders at MIT Koch Institute
accessnewswire.com
BIIB
ALNY
MRNA
REGN
JNJ
BEAM
IONS